Intensity Therapeutics Inc. INTS
3.80
(0.21)
(5.24%)
as of 25 Sep
- Market cap
- $12.7M
- P/E
- 0.0×
Follow INTS
| Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | Dec '24 | Dec '25 | |
|---|---|---|---|---|---|---|---|
Current Ratio |
7.67 | 7.04 | 1.27 | 0.21 | 3.91 | 1.92 | 5.92 |
Net Debt/EBITDA |
1.43 | 1.47 | 0.56 | 0.18 | 1.83 | 0.15 | 0.99 |
Debt/Assets |
2.89% | 3.21% | 2.75% | 0.00% | 0.80% | 2.30% | 0.56% |
Debt/Equity |
0.03 | 0.04 | 0.11 | 0.00 | 0.01 | 0.04 | 0.01 |
Asset Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF/Net income |
0.82 | 0.89 | 0.86 | 0.72 | 0.61 | 0.94 | 0.80 |
Capex/Depreciation |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| 0.00% | 312.47% | 154.16% | 63.76% | 1,225.41% | (202.34%) | (156.90%) | |
| 0.00% | (62.96%) | (102.77%) | (217.46%) | (124.52%) | (147.37%) | (122.92%) | |
ROIC |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | (2,366.58%) | (22,007.35%) |
Return on Tangible Assets |
(69.21%) | (74.16%) | (782.05%) | 141.24% | (103.10%) | (1,011.69%) | (109.87%) |
Average Days of Receivables |
0.00 | 0.00 | 0.00 | 0.00 | — | — | — |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Share Based Compensation of Revenue |
— | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Free Cash Flow per Share |
(0.34) | (19.69) | (25.03) | (40.15) | (20.91) | (27.37) | (6.81) |
Cash per Share |
0.64 | 34.15 | 16.64 | 9.62 | 42.88 | 4.66 | 8.79 |
Shareholders Equity per Share |
0.59 | 30.94 | 4.82 | (37.38) | 38.20 | 5.25 | 8.76 |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Book value per Share |
0.59 | 30.94 | 4.82 | (37.38) | 38.20 | 5.25 | 8.76 |
Free Cash Flow |
(4.42) | (5.37) | (6.83) | (5.48) | (7.20) | (15.22) | (9.23) |
Working Capital |
7.52 | 8.13 | 1.01 | (5.37) | 11.51 | 1.61 | 10.56 |
Net Current Asset Value |
7.34 | 7.77 | 0.83 | (5.40) | 11.33 | 1.50 | 10.48 |
| Other line items | |||||||
Quick Ratio |
7.47 | 6.92 | 1.22 | 0.19 | 3.73 | 1.48 | 5.56 |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Cash ROIC |
(28.55%) | (29.70%) | (113.81%) | 144.66% | (25.66%) | (270.91%) | (38.67%) |
Accounts Receivable Turnover |
— | 0.00 | 0.00 | 0.00 | — | — | — |
Accounts Payable Turnover |
— | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Inventory Turnover |
— | — | — | 0.00 | — | — | — |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Days of Inventory on Hand |
— | — | — | 0.00 | — | — | — |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Operating CF per Share |
(0.34) | (19.69) | (25.03) | (40.15) | (20.91) | (27.37) | (6.81) |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Average Receivables |
— | 0.05 | 0.06 | 0.06 | — | — | — |
Average Payables |
— | 0.31 | 0.20 | 0.39 | 1.83 | 2.13 | 0.90 |
Average Assets |
— | 9.58 | 7.68 | 3.49 | 9.53 | 11.04 | 9.44 |
Average Common Equity |
— | (1.93) | (5.12) | (11.89) | (0.97) | 8.04 | 7.40 |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates